1990

1. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year

   Journal of Autoimmunity, Vol. 3, Núm. 5, pp. 625-638